Pure Global

Complementary Medicine in Multiple Sclerosis - Trial IRCT20181113041641N2

Access comprehensive clinical trial information for IRCT20181113041641N2 through Pure Global AI's free database. This Phase 3 trial is sponsored by Artesh University of Medical Sciences and is currently Completed. The study focuses on Multiple sclerosis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20181113041641N2
Phase 3
Completed
Trial Details
Iranian Registry Of Clinical Trial โ€ข IRCT20181113041641N2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Complementary Medicine in Multiple Sclerosis
Effects of Dietary Modification Based on Complementary and Alternative Iranian Medicine in Patients with Secondary-Progressive Multiple Sclerosis

Study Focus

Multiple sclerosis

Interventional

Sponsor & Location

Artesh University of Medical Sciences

Iran

Timeline & Enrollment

Phase 3

Aug 22, 2022

N/A

ICD-10 Classifications

Multiple sclerosis
Progressive systemic sclerosis
Systemic sclerosis
Systemic sclerosis, unspecified
Diffuse sclerosis

Data Source

Iranian Registry Of Clinical Trial

IRCT20181113041641N2

Non-Device Trial